(All fields required)
Please enter a valid email.
Please enter your name.
Julia S. Anixt, MD Pediatrician, Developmental and Behavioral Pediatrics
Pediatrician, Developmental and Behavioral Pediatrics
Assistant Professor, UC Department of Pediatrics
Attention Deficit / Hyperactivity Disorder (ADHD); Autism Spectrum Disorders (ASD); learning difficulties; developmental and behavioral issues in underserved populations; developmental outcomes in children with congenital heart disease
ADHD; use of shared decision making for the treatment of challenging behavior in children with ASD; the diagnosis and management of behavioral and mental health issues in primary care settings; access to care for underserved populations
Julia Anixt, MD, is a developmental-behavioral pediatrician conducting clinical research on Attention Deficit/ Hyperactivity Disorder (ADHD). In particular her work focuses on improving the quality of care for ADHD diagnosis and treatment for children in underserved communities and assessing the impact of parent and youth perceptions about ADHD on treatment decisions. Her research also focuses on implementing Shared Decision Making (SDM) in the clinical setting for families of children with Autism Spectrum Disorders (ASD) contemplating the use of medication to target challenging behaviors.
Anixt JS, Copeland-Linder N, Haynie D, Cheng TL. Burden of Unmet Mental Health Needs in Assault-Injured Youths Presenting to the Emergency Department. Academic Pediatrics. 2012; 12(2): 125-30.
Froehlich TE, Anixt JS, Loe IM, Chirdkiatgumchai V, Kuan L, Gilman RC. Update on Environmental Risk Factors for Attention-Deficit/Hyperactivity Disorder. Current Psychiatry Reports. 2011; 13(5): 333-44.
Olaniyan O, dosReis S, Garriett V, Mychailyszyn MP, Anixt J, Rowe PC, Cheng TL. Community Perspectives of Childhood Behavioral Problems and ADHD among African-American Parents. Ambulatory Pediatrics. 2007; 7(3): 226-231. dosReis S, Butz A, Lipkin PH, Anixt JS, Weiner CL, Chernoff R. Attitudes About Stimulant Medication for Attention-Deficit/Hyperactivity Disorder Among African American Families in an Inner City Community. The Journal of Behavioral Health Services Research. 2006;33(4): 423-430.
William B. Brinkman, MD, MEd Physician Lead, James M. Anderson Center Rapid Evidence Adoption to improve Child Health (REACH) team
Physician Lead, James M. Anderson Center Rapid Evidence Adoption to improve Child Health (REACH) team
Associate Director, NRSA Primary Care Research Fellowship in Child and Adolescent Health
Research Director, Cincinnati Pediatric Research Group
Attending Physician, Hospital Medicine
Associate Professor, UC Department of Pediatrics
Shared decision making; knowledge translation; family centered care; quality improvement; implementation science; attention-deficit/hyperactivity disorder (ADHD); asthma; family/self-management of chronic conditions
MD: St. Louis University, St. Louis, MO, 1999.
Residency: Pediatrics, The Children's Memorial Hospital, Northwestern University, Feinberg School of Medicine, Chicago, IL, 2002.
Chief Residency: Pediatrics, The Children's Memorial Hospital, Chicago, IL, 2003.
Fellowship: NRSA Primary Care Research Fellowship, General & Community Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2006.
MEd: University of Cincinnati, Cincinnati, OH, 2006.
Certification: Pediatrics, 2002.
Brinkman WB, Sherman SN, Zmitrovich AR, Visscher MO, Crosby LE, Phelan KJ, Donovan EF. In their own words: adolescent views on ADHD and their evolving role managing medication. Acad Pediatr. 2012 Jan-Feb;12(1):53-61.
Brinkman WB, Hartl J, Rawe L, Sucharew H, Britto MT, Epstein JN. Physicians’ shared decision making behaviors in attention-deficit/hyperactivity disorder care. Arch Ped Adolesc Med. 2011 Nov;165(11):1013-9.
Lipstein EA, Brinkman WB, Britto MT. What is known about parent’s treatment decisions? A narrative review of pediatric decision making. Med Decis Making. 2012 Mar-Apr;32(2):246-58.
Brinkman WB, Epstein JN. Promoting productive interactions between parents and physicians in the treatment of children with attention-deficit/hyperactivity disorder. Expert Rev Neurother. 2011 Apr;11(4):579-88.
Brinkman WB, Epstein JN. Treatment planning for children with attention-deficit/hyperactivity disorder: treatment utilization and family preferences. Patient Prefer Adherence. 2011 Jan 17;5:45-56.
Epstein JN, Langberg JM, Lichtenstein PK, Altaye M, Brinkman WB, House K, Stark LJ. Attention-deficit/hyperactivity disorder outcomes for children treated in community-based pediatric settings. Arch Pediatr Adolesc Med. 2010 Feb;164(2):160-5.
Brinkman WB, Sherman SN, Zmitrovich AR, Visscher MO, Crosby LE, Phelan KJ, Donovan EF. Parental angst making and revisiting decisions about treatment of attention-deficit/hyperactivity disorder. Pediatrics. 2009 Aug;124(2):580-9.
Langberg JM, Brinkman WB, Lichtenstein PK, Epstein JN. Interventions to promote the evidence-based care of children with ADHD in primary-care settings. Expert Rev of Neurother. 2009 Apr;9(4):477-87. Brinkman WB, Geraghty SR, Lanphear BP, Khoury JC, Gonzalez del Rey JA, DeWitt TG, Britto MT. Effect of multisource feedback on resident communication skills and professionalism: a randomized controlled trial. Arch Pediatr Adolesc Med. 2007 Jan;161(1):44-9.
Brinkman WB, Geraghty SR, Lanphear BP, Khoury JC, Gonzalez del Rey JA, DeWitt TG, Britto MT. Evaluation of resident communication skills and professionalism: a matter of perspective?Pediatrics. 2006 Oct;18:1371-9.
Medication Continuity in Children Treated for ADHD. Principal Investigator. Mentored Patient-Oriented Research Career Development Award, National Institute of Mental Health. Jan 2010 - Nov 2014.
HPV Vaccine Decision Aid Development. Co-Investigator. CCHMC Place Research Outcomes Award. Jul 2011 - Jun 2013.
Pursuing Perfection in Pediatric Therapeutics. Co-investigator Agency for Healthcare Research and Quality Oct 2011 - Sept 2016
Explaining Racial Disparities in Child Asthma Morbidity. Co-investigator. National Institutes of Allergy and Infectious Diseases. Apr 2010 - Mar 2014.
Clinical & Translational Science Award. Co-investigator. National Center for Research Resources. Apr 2009 - Mar 2014.
Collaborative Ohio Inquiry Networks (COIN) Research Center. Co-investigator. Agency for Healthcare Research and Quality. Sept 2012 - Aug 2017.
Jeffrey N. Epstein, PhD Director, Center for ADHD, Behavioral Medicine and Clinical Psychology
Director, Center for ADHD, Behavioral Medicine and Clinical Psychology
Professor, UC Department of Pediatrics
Attention deficit hyperactivity disorder (ADHD)
Jeff Epstein, PhD, is a professor of pediatrics in Behavioral Medicine and Clinical Psychology at Cincinnati Children's Hospital Medical Center. He earned his doctorate in clinical psychology from State University of New York at Stony Brook and completed a clinical internship at the Medical University of South Carolina.
Dr. Epstein is a licensed psychologist whose research and clinical work focus on the diagnosis and treatment of ADHD and other psychological disorders originating in childhood.
He is a co-investigator on the Multimodal Treatment Study of Children with ADHD (MTA). Dr. Epstein has published numerous empirical papers on a variety of ADHD-related topics. Much of his empirical research has concentrated on the neuropsychology of ADHD, and the promotion of evidence-based ADHD care among community pediatricians.
Epstein JN. How can the internet help improve community-based pediatric ADHD care? Expert Review of Neurotherapeutics. 2012;12, 501-503.
Becker SP, Langberg JM, Vaughn AJ, Epstein JN. Clinical utility of the Vanderbilt ADHD Diagnostic Parent Rating Scale comorbidity screening scales. Journal of Developmental and Behavioral Pediatrics. 2012;33, 221-228.
Shiels K, Tamm L, Epstein JN. Deficient post-error slowing in children with ADHD is limited to the inattentive subtype. Journal of the International Neuropsychological Society. 2012;18, 1-6.
Froehlich TE, Epstein JN, Nick TG, Melguizo-Castro MS, Stein MA, Brinkman WB, Graham AJ, Langberg JM, Kahn RS. Pharmacogenetic predictors of methylphenidate dose-response in Attention-Deficit/Hyperactivity Disorder. Journal of the American Academy of Child and Adolescent Psychiatry. 2011;50, 1129-1139.
Brinkman WB, Hartl J, Rawe L, Britto MT, Epstein JN. Physicians’ shared decision making behaviors in Attention-Deficit/Hyperactivity Disorder care. Archives of Pediatrics and Adolescent Medicine. 2011;165, 1013-1019.
Vaughn A, Epstein J, Rausch J, Altaye M, Langberg J, Newcorn J, Hinshaw S, Hechtman L, Arnold LE, Swanson J, Wigal T. Relations between neuropsychological functioning and ADHD symptomatology over time. Journal of Abnormal Child Psychology. 2011;39, 853-864
Epstein JN, Langberg JM, Rosen PJ, Graham A, Narad ME, Antonini TN, Brinkman WB, Froehlich T, Simon JO, Altaye M. Evidence for higher reaction time variability for children with ADHD on a range of cognitive tasks including reward and event rate manipulations. Neuropsychology. 2011;25, 427-441.
Epstein JN, Langberg JM, Lichtenstein PK, Kolb R, Altaye M, Simon JO. Use of a web portal to improve community-based pediatric ADHD care: A cluster randomized trial. Pediatrics. 2011;128, e1201-e1208.
Langberg JM, Molina BSG, Arnold LE, Epstein JN, Altaye M, Hinshaw SP, Swanson JM, Wigal T, Hechtman L. Patterns and predictors of adolescent academic achievement and performance in a sample of children with Attention-Deficit/Hyperactivity Disorder (ADHD). Journal of Clinical Child and Adolescent Psychology. 2011;40, 1-13.
Epstein JN, Brinkman WB, Froehlich T, Langberg JM, Narad ME, Antonini TN, Shiels K, Simon JO, Altaye M. Effects of stimulant medication, incentives, and event rate on reaction time variability in children with ADHD. Neuropsychopharmacology. 2011;36, 1060-1072.
Tanya Elizabeth Froehlich, MD, MS, FAAP
Dr. Froehlich is a developmental-behavioral pediatrician who cares for school age children with learning and behavioral issues. Her research has a special focus on attention-deficit/hyperactivity disorder (ADHD), and approaches the disorder from the vantage points of epidemiology, etiology, and treatment. She conducted a study reporting the national prevalence of ADHD in U.S. children based on DSM-IV criteria (published in the Archives of Pediatrics and Adolescent Medicine) which showed that children from disadvantaged socioeconomic backgrounds were most likely to meet criteria for ADHD, yet least likely to receive consistent ADHD pharmacotherapy. Interested in understanding why certain children (including those with low socioeconomic status) may be more vulnerable to ADHD than others, she also studies the contribution of environmental exposures to ADHD and their public health impact. In Pediatrics, she published the first study to investigate the interactive effects of prenatal tobacco exposure and childhood lead exposure on ADHD and demonstrated that the association between poverty and ADHD is partially explained by the effects of these common environmental toxicants. She has also examined possible gene-environment interactions and found that boys with specific dopamine-related genetic variants were particularly susceptible to the adverse effects of lead exposure on ADHD-related executive functioning (published in Biological Psychiatry). Dr. Froehlich continues to research environmental influences on ADHD as a co-investigator on a National Institute of Environmental Health Sciences R01 grant which is examining the effects of pyrethroid pesticide exposure on ADHD symptoms and executive functioning.
Dr. Froehlich’s research agenda also addresses ADHD treatment. She is the recipient of a National Institute of Mental Health K23 Award aimed at identifying genetic and phenotypic predictors of ADHD medication response. Recently, she authored a paper in the Journal of the American Academy of Child and Adolescent Psychiatry showing that individuals with the dopamine receptor D4 and dopamine transporter genotypes believed to confer lower susceptibility to ADHD had greater improvement in their hyperactive-impulsive symptoms with methylphenidate treatment than those with the “high risk” genetic variants. She also coauthored a study on a novel genotyping assay for carboxylesterase 1 (CES1), the enzyme which metabolizes methylphenidate, and is currently undertaking a study on CES1 genetic variants’ effects on methylphenidate response.
Dr. Froehlich also enhances care for children with ADHD through teaching and other professional activities. She has served as an invited speaker providing seminars for professionals and workshops for families in international, national, and regional forums. Currently, Dr. Froehlich co-chairs the Society for Developmental and Behavioral Pediatrics ADHD Special Interest Group, and coordinates ADHD-related projects and educational seminars for the Society membership in this capacity.
BA: East Asian Studies, Columbia University, 1992.
MD: Yale University School of Medicine, 1999.
MS: Epidemiology, University of Cincinnati, 2007.
Pediatric Intern: Children’s Hospital of Philadelphia, 1999-2000.
Pediatric Resident: Children’s Hospital of Philadelphia, 2000-2002.
Fellowship: Developmental and Behavioral Pediatrics, Cincinnati Children’s Hospital, 2002-2005; General Pediatrics National Research Service Award Fellow, Cincinnati Children’s Hospital, 2004-2007.
Zhu HJ, Brinda B, Froehlich TE, Markowitz JS. A Discriminative Analytical Method for Detection of CES1A1 and CES1A2/CES1A3 Genetic Variants. Pharmacogenetics and Genomics. 2012; 22(3): 215-218.
Froehlich TE, Epstein JN, Nick TG, Melguizo Castro MS, Stein MA, Brinkman WB, Graham AJ, Langberg JM, Kahn RS. Pharmacogenetic Predictors of Methylphenidate Dose-Response in Attention-Deficit/Hyperactivity Disorder. Journal of the American Academy of Child and Adolescent Psychiatry. 2011;11:1129-1139.
Froehlich TE, Anixt J, Loe IM, Chirdkiatgumchai V, Kuan L, Gilman R. Update on Environmental Risk Factors for Attention-Deficit/Hyperactivity Disorder. Current Psychiatry Reports. 2011;13(5):333-44.
Epstein JN, Brinkman WB, Froehlich T, Langberg JM, Narad ME, Antonini TN, Shiels K, Simon JO, Altaye M. Effects of stimulant medication, incentives, and event rate on reaction time variability in children with ADHD. Neuropsychopharmacology. 2011; 36(5): 1060-1072.
Langberg JM, Vaughn AJ, Brinkman WB, Froehlich T, Epstein, JN. Clinical utility of the Vanderbilt ADHD rating scale for identifying children without comorbid learning disorders. Pediatrics. 2010; 126: e1033-e1038.
Froehlich TE, McGough JJ, Stein MA. Progress and Promise of ADHD Pharmacogenetics. CNS Drugs. 2010; 24: 99-117.
Froehlich TE, Lanphear BP, Auinger P, Hornung R, Epstein JN, Braun J, Kahn RS. The Association of Tobacco and Lead Exposure with Attention-Deficit/Hyperactivity Disorder in a National Sample of U.S. Children. Pediatrics. 2009; 124: e1054-63.
Langberg JM, Froehlich TE, Loren RE, Martin JE, Epstein JN. Assessing Children with ADHD in Primary Care Settings. Expert Review of Neurotherapeutics. 2008; 8: 627-41.
Froehlich TE, Lanphear BP, Epstein JN, Barbaresi WJ, Katusic SK, Kahn RS. Prevalence and Treatment of ADHD in a National Sample of U.S. Children. Archives of Pediatrics and Adolescent Medicine. 2007;161(9): 857-864.
Froehlich TE, Lanphear BP, Dietrich KN, Cory-Slechta DA, Wang N, Kahn RS. Interactive Effects of a DRD4 Polymorphism, Lead, and Sex on Executive Functions in Children. Biological Psychiatry. 2007; 62: 243-249.
Medication Response in Children with Predominantly Inattentive Type ADHD. Principal Investigator. National Institute of Mental Health Career Development (K23). 2009-2014.
Mechanisms of Pesticide-Induced Neurobehavioral Deficits: Relevance to ADHD. Co-Investigator. National Institute of Environmental Health Sciences (R01). 2010-2013.
Phillip K. Lichtenstein, MD Pediatrician, General & Community Pediatrics
Pediatrician, General & Community Pediatrics
Nicholas Newman, DO, MS, FAAP Physician, Division of General and Community Pediatrics
Physician, Division of General and Community Pediatrics
Medical Director, Pediatric Environmental Health and Lead Clinic
Pediatric Primary Care Center
Nicholas Newman, DO, MS, FAAP, is board certified in general pediatrics as well as occupational/environmental medicine. He is interested understanding how toxicants in and around a child’s home or school can affect children's health. He is also interested in developing approaches to prevent or mitigate these effects at an individual and at a community level. His recent research has examined the effect of traffic related air pollution exposure on neurobehavioral problems in children as well as the impact of air pollution on asthma in children.
BS: Massachusetts Institute of Technology, Cambridge, MA, 1990.
DO: Kirksville College of Osteopathic Medicine, Kirksville, MO, 1997.
Rotating Internship: Horizon Health System/Henry Ford Health System, Michigan State University, Detroit, MI, 1998.
Residency: Pediatrics, Children’s Hospital of Michigan, Wayne State University, Detroit, MI, 2001.
Fellowship: Occupational and Environmental Medicine, University of Cincinnati, Cincinnati, OH, 2011.
MS: University of Cincinnati, Department of Environmental Health, Cincinnati, OH, 2011.
Certification: American Board of Pediatrics, 2001 (renewed 2008); American Board of Preventive Medicine, 2013
Beck AF, Huang B, Simmons JM, Moncrief T, Sauers HS, Ryan PH, Newman NC, Kahn RS. Role of Financial and Social Hardships in Asthma Racial Disparities. Pediatrics. 2014 Feb 2 [Epub ahead of print].
Newman NC, Ryan P, Lemasters G, Levin L, Bernstein D, Hershey GK, et al. Traffic-related air pollution exposure in the first year of life and behavioral scores at 7 years of age. Environ Health Perspect. 2013 Jun;121(6):731-6.
Genter M, Newman N, Shertzer H, Syed A, Bolon B. Distribution and Systemic Effects of Intranasally Administered 25 nm Silver Nanoparticles in Adult Mice. Toxicologic Pathology. May 4, 2012, 00:10-10, 2012.
Hudson N, Calvert G, Newman N, et al. Acute Illnesses Associated with Insecticides used to Control Bed Bugs --- Seven States 2003-2010. MMWR. Sep 23, 2011 / 60(37);1269-1274.
L Trasande, NC Newman, L Long, G Howe, BJ Kerwin, RJ Martin, SA Gahagan, WB Weil. Translating Knowledge About Environmental Health to Practitioners: Are We Doing Enough?Mount Sinai Journal of Medicine. 77:114-123, 2010.
Suzanne R. Plummer, PsyD Staff Psychologist, Behavioral Medicine and Clinical Psychology
Staff Psychologist, Behavioral Medicine and Clinical Psychology
ADHD; anxiety; depression; behavior disorders
Leanne Tamm, PhD
ADHD; ADHD subtypes; non-medication interventions; early intervention and prevention; treatment outcomes; brain-behavior relationships; gene-environment interactions; motivation
Tamm L, Hughes C, Ames L, Pickering J, Silver CH, Stavinoha P, Castillo CL, Rintelmann J, Moore J, Foxwell A, Bolanos SG, Hines T, Nakonezny PA, Emslie G. Attention training for school-aged children with ADHD: results of an open trial. J Atten Disord. 2010 Jul;14(1):86-94.
Lakes, KD, Kettler, RJ, Schmidt, J, Haynes, M, Feeney-Kettler, K, Swanson, JM, & Tamm, L. The CUIDAR Early Intervention Parent Training Program for Preschoolers at Risk for Behavioral Disorders: An Innovative Practice for Reducing Disparities in Access to Service. Journal of Early Intervention. 2009;31:167-78.Tamm L, Carlson CL. Task demands interact with the single and combined effects of medication and contingencies on children with ADHD. J Atten Disord. 2007 May;10(4):372-80.
Tamm L, Menon V, Reiss AL. Parietal attentional system aberrations during target detection in adolescents with attention deficit hyperactivity disorder: event-related fMRI evidence. Am J Psychiatry. 2006 Jun;163(6):1033-43.
Tamm L, Swanson JM, Lerner MA, Childress C, Patterson B, Lakes KD, Nguyen A, Kudo M, Altamirano W, Miller J, Santoyo R, Camarero-Morse V, Watkins JM, Simpson S, Waffarn F, Cunningham C. Intervention for preschoolers at risk for attention-deficit/hyperactivity disorder (ADHD): service before diagnosis. Clin Neurosci Res. 2005;5:247-253.
Tamm L. Attention Deficit Hyperactivity Disorder. In New Encyclopedia of Neuroscience, L.R. Squire (Ed.). Oxford: Academic Press, 2009.
Tamm L, McCandliss BD, Liang A, Wigal TL, Posner, MI, Swanson, JM. Can attention itself be trained? Attention training for children at risk for ADHD. In Attention Deficit/Hyperactivity Disorder: Concepts, Controversies, New Directions, Medical Psychiatry Series. Vol. 37. New York: Informa Healthcare, 2007.
Aaron J. Vaughn, PhD
Assessment and treatment of children and adolescents with ADHD; organization / academic skills
Aaron Vaughn, PhD, is an assistant professor of pediatrics in Behavioral Medicine and Clinical Psychology at Cincinnati Children's Hospital Medical Center. He earned his MS in clinical psychology from Purdue University, a doctorate in clinical psychology from University of Vermont and completed a clinical internship and postdoctoral fellowship at Cincinnati Children’s Hospital Medical Center. Dr. Vaughn specializes in the assessment and behavioral management of children and adolescents with attention-deficit / hyperactivity disorder and related conditions.
Research interests include the assessment and treatment of ADHD including better understanding of the social, academic, and behavioral impairments exhibited by children and adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD) from a developmental psychopathology perspective. Dr. Vaughn’s research is targeted in applying what is learned toward increasing the effectiveness of evidence-based treatments for children and adolescents with ADHD.
In particular, Dr. Vaughn’s research is concentrated around:
BA: Cedarville University.
MS: Clinical Psychology, Purdue University.
PhD: Clinical Psychology, University of Vermont.
Predoctoral Internship: Cincinnati Children's Hospital Medical Center, 2008-2009.
Postdoctoral Fellowship: Cincinnati Children's Hospital Medical Center, 2009-2011.
Hoza B, Vaughn A, Waschbusch DA, Murray-Close D, McCabe G. Can children with ADHD be motivated to reduce bias in self-reports of competence?Journal of Consulting & Clinical Psychology. 2012;80, 245-254.
Vaughn AJ, Hoza B. The incremental utility of rating scales and a structured diagnostic interview in the assessment of ADHD. Journal of Emotional and Behavioral Disorders. 2012.
Zelaznik H, Vaughn A, Smith A, Hoza B, Green J, Linnea K. Timing deficits in children with Attention Deficit/Hyperactivity Disorder. Human Movement Science. 2012. 31, 255-265.
McQuade JD, Vaughn AJ, Hoza B, Murray-Close D, Molina BSG, Arnold LE, Hechtman L. Perceived social acceptance and peer status differentially predict adjustment in youth with and without ADHD. Journal of Attention Disorders. 2012.
Langberg JM, Becker SP, Epstein JN, Vaughn AJ, Girio-Herrera E. Predictors of response and mechanisms of change in an organizational skills intervention for students with ADHD. Journal of Child and Family Studies. 2012.
Langberg JM, Epstein JN, Becker SP, Girio-Herrera E, Vaughn AJ. Evaluation of the Homework, Organization, and Planning Skills (HOPS) intervention for middle school students with ADHD as implemented by school mental health providers. School Psychology Review. 2012;42, 342-364.
Vaughn AJ, Epstein J, Rausch J, Altaye M, Langberg J, Newcorn J, Hinshaw S, Hechtman L, Arnold LE, Swanson J, Wigal T. Relations between outcomes on a continuous performance test and ADHD symptoms over time. Journal of Abnormal Child Psychology. 2011. 39, 853-864.
Langberg JM, Vaughn AJ, Brinkman WB, Froehlich T, Epstein JN. Clinical utility of the Vanderbilt ADHD rating scale for identifying children without comorbid learning disorders. Pediatrics. 2010;126, 1033-1038.
2/2 Multisite Study of School Based Treatment Approaches for ADHD Adolescents. Co-Investigator (Principal Investigator, Langberg). National Institute of Mental Health (NIMH). July 2009-June 2014. R01.
Evaluation of an Intervention for Improving Community-Based Pediatric ADHD Care. Co-Investigator (Principal Investigator, Epstein). National Institute of Mental Health (NIMH). July 2010-June 2015. R01.
Reading ICARD: Interventions for Children with Attention and Reading Disorders. Co-Investigator (Principal Investigator, Denton). NICHD. R01.
Disseminating a Model Intervention to Promote Improved ADHD Care in the Community. Co-Investigator (Principal Investigator, Epstein). National Institute of Mental Health (NIMH). July 2010-June 2015. R21.
Annie Garner Clinical Resident, Center for ADHD
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4200 | 1-800-344-2462 | TTY:1-513-636-4900
New to Cincinnati Children’s or live outside of the Tristate area? 1-877-881-8479
© 1999-2014 Cincinnati Children's Hospital Medical Center